All blog items

Labs at Duke and other academic centers collaborate to identify alternatives to antibiotics Antibiotics are currently the only treatments available for Lyme disease and other tick-borne illnesses, but researchers at Duke Health are working to expand the medical toolkit by identifying vulnerable areas of disease-causing bacteria that could lead to innovative therapies.

Listen to Kevin’s message to Duke University Hospital employees: [Video:https://youtu.be/MqgVRI_wtzo]

    VIETNAM, 1970

A drug already used to treat certain forms of cancer may also be an effective therapy for Huntington’s disease, according to a new study in the latest issue of Science Translational Medicine. The same study also increases our understanding of how this drug, and other medications like it, may offer hope for other neurodegenerative diseases like Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and Parkinson’s disease.

Suresh Balu has been named Associate Dean for Innovation and Partnership for the Duke University School of Medicine, effective immediately. In this new role, Suresh will be responsible for creating, implementing, and sustaining innovation and partnership initiatives for the School of Medicine, specifically, to support the strategic priorities for clinical and translational research. He will be responsible for developing and strengthening relationships across Duke Health and Duke University and with key stakeholders external to Duke. 

As a PCLT student, I have had the opportunity to delve deeper into the topics of population health management throughout my medical education. During my second year, I engaged in 8 months of outpatient clinical training in Duke Primary Care (DPC) clinics and was introduced to the challenges of delivering optimal care in that setting. I wanted to use my third year research project as a way to gain a better understanding of the innovative health approaches that are addressing those barriers to patient care, particularly in chronic disease management.

When I joined Duke eight years ago as faculty in the Department of Community and Family Medicine’s Division of Community Health, after departing UNC School of Public Health, my career as a public health researcher focused mainly on leading community-engaged research interventions to address health inequities of underserved populations; over the years, I have become more heavily involved in health professions education and training.  Today, many of my professional endeavors are focused on providing population health improvement training to health professionals using a community-engaged

Trying to be an informed healthcare consumer in the United States is harder than you might think, according to researchers from the Duke-Margolis Center for Health Policy. When consumers search for healthcare prices online, only 17 percent of sites provide information on the price of common procedures, making it difficult for patients without insurance, who have high-deductible plans, or whose plans include other kinds of cost sharing to determine how much their care will cost and what they will pay out of pocket.

 

Gene-editing Pioneer Jennifer Doudna Delivers Lefkowitz Lecture Basic Science Day and the Robert J. Lefkowitz, MD, Distinguished Lecture on Wednesday, November 29, 2017, drew hundreds of faculty, staff and students from across the School of Medicine and campus. School of Medicine Dean Mary E. Klotman opened the meeting, which  was hosted by Vice Dean for Basic Science Raphael Valdivia and featured faculty speakers representing all of the School’s basic science departments as well as a student poster session.